You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聯邦製藥(03933.HK)獲授予2億元貸款額度
阿思達克 12-16 08:31
聯邦製藥(03933.HK)公佈,公司作爲借款方,與中國光大銀行香港分行簽訂貸款協議,獲授予2億元的貸款額度。 該貸款額度須於接受該貸款協議後3個月內提取。該額度的貸款於首次提取後的第18個月、24個月、30個月及36個月,分別按貸款額度有效期末的未償還貸款的10%、20%、20%及50%分期償還。 該貸款協議規定蔡海山、蔡紹哲、寧桂珍及他們的家族信託不得個別或共同不再爲公司的單一最大股東;並必須個別或共同持有公司全部已發行股本的最少40%;及不得不再是董事會主席及對公司擁有管理控制權。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account